Biomarin Pharmaceutical Ratios (2009-2026) | BMRN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	74.67%	74.67%	73.38%	77.48%	76.93%	76.99%	72.72%	77.29%	78.06%	77.97%	78.66%	80.71%	81.68%	74.73%	81.78%	79.66%	81.82%	81.95%	68.47%	74.55%
EBT Margin (Quarter)	2.82%	-11.29%	-14.80%	25.84%	6.53%	-0.38%	-3.27%	9.52%	11.90%	7.17%	2.99%	16.27%	18.56%	18.03%	22.70%	31.95%	36.09%	-3.39%	-3.10%	18.43%
EBIT Margin (Quarter)	2.33%	-13.02%	-14.65%	26.44%	7.33%	-0.48%	-2.43%	10.46%	11.01%	5.25%	4.22%	13.63%	16.92%	15.27%	21.60%	30.05%	33.55%	-6.02%	-5.10%	16.92%
EBITDA Margin (Quarter)	2.33%	-13.02%	-14.65%	26.44%	7.33%	-0.48%	-2.43%	10.46%	11.01%	5.25%	4.22%	13.63%	16.92%	15.27%	21.60%	30.05%	33.55%	-6.02%	-5.10%	16.92%
Operating Margin (Quarter)	2.33%	-13.02%	-14.65%	26.44%	7.33%	-0.48%	-2.43%	10.46%	11.01%	5.25%	4.22%	13.63%	16.92%	15.27%	21.60%	30.05%	33.55%	-6.02%	-5.10%	16.92%
Net Margin (Quarter)	2.58%	-8.93%	-12.87%	23.26%	5.18%	-1.32%	-0.05%	8.53%	9.41%	6.95%	3.15%	13.66%	15.05%	14.22%	16.72%	24.92%	29.14%	-3.96%	-5.33%	13.77%
FCF Margin (Quarter)	21.65%	23.57%	1.11%	-14.30%	17.65%	31.92%	-23.50%	-16.50%	14.93%	12.64%	9.92%	3.22%	13.68%	27.22%	22.23%	21.15%	22.84%	41.21%	6.74%	26.07%
Efficiency
Inventory Average (Quarter)	712.45M	730.19M	763.04M	781.51M	794.34M	820.89M	866.77M	906.50M	947.23M	1,003.85M	1,069.67M	1,122.58M	1,160.80M	1,181.48M	1,206.00M	1,253.75M	1,307.51M	1,361.17M	1,340.53M	1,286.05M
Assets Average (Quarter)	5,851.77M	5,937.99M	5,991.12M	6,033.74M	6,104.27M	6,204.94M	6,319.56M	6,404.38M	6,498.43M	6,660.67M	6,799.88M	6,857.14M	6,969.90M	6,959.16M	6,920.07M	7,067.97M	7,301.67M	7,535.60M	7,604.44M	8,092.52M
Invested Capital (Quarter)	32.20M	48.20M	48.23M	64.00M	29.95M	28.30M	15.93M				493.88M	494.36M	494.84M
Asset Utilization Ratio (Quarter)	0.33	0.31	0.31	0.31	0.31	0.32	0.33	0.34	0.34	0.35	0.36	0.36	0.37	0.40	0.41	0.42	0.42	0.41	0.42	0.40
Leverage & Solvency
Interest Coverage Ratio (Quarter)	3.06	-13.75	-3.28	36.08	10.15	-0.52	6.34	16.85	17.46	8.08	1.27	24.53	33.38	36.40	53.01	78.20	72.14	-18.10	-6.09	7.45
Debt Ratio (Quarter)	0.01	0.01	0.01	0.01	0.00	0.00	0.00				0.07	0.07	0.07						0.08	0.17
Times Interest Earned (Quarter)	3.06	-13.75	-3.28	36.08	10.15	-0.52	6.34	16.85	17.46	8.08	1.27	24.53	33.38	36.40	53.01	78.20	72.14	-18.10	-6.09	7.45
Valuation
Enterprise Value (Quarter)	-1123.40M	-1079.48M	-1013.88M	-1056.24M	-1109.75M	-1273.77M	-1291.54M	-1152.09M	-1170.96M	-1125.85M	-1073.81M	-1046.58M	-1224.35M	-930.44M	-1137.71M	-1272.34M	-1432.12M	-1477.84M	-1560.61M	-2222.43M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-1.31%	-1.25%	-1.51%	0.54%	1.02%	1.90%	2.81%	1.48%	1.91%	2.64%	3.30%	3.67%	4.52%	5.61%	7.67%	9.62%	11.73%	9.14%	5.98%	4.32%
Return on Invested Capital (Quarter)	0.01%	0.00%	-0.01%	0.00%	0.00%	0.01%	0.01%	0.01%	0.02%	0.05%	0.01%	0.00%	0.00%	0.00%	0.00%	0.01%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Biomarin Pharmaceutical Ratios (2009-2026) | BMRN

Research Tools

Developers

Biomarin Pharmaceutical Ratios (2009-2026) | BMRN

Create an account

Sign In

Reset Password